| || |
|Ms. Lorraine Nolan, Chief Executive |
Lorraine Nolan is a chemist having completed her Ph.D. and post-doctoral research at Trinity College Dublin in transdermal drug delivery. She worked for a number of years in private industry in the area of enhancing and developing drug delivery systems, and also within the state forensic science services.
Ms Nolan joined the HPRA in 2001 and since that time has held a number of different roles at senior level within the organisation across a range of areas including inspection and authorisation of human medicines, medical devices, cosmetics and controlled substances. Prior to assuming the role of Chief Executive she was Director of Human Products Authorisation & Registration. Ms Nolan is a member of the Management Board of the European Medicines Agency.
| || |
Ms. Rita Purcell, Deputy Chief Executive
Rita Purcell joined the Irish Medicines Board in 1996 heading up the Finance and Corporate Affairs Department. Her responsibilities include finance, legal, corporate policy, property, secretariat and international affairs. Ms Purcell also sits on the Management Board of the European Medicines Agency and is on the Council of the Pharmaceutical Society of Ireland, the regulator of pharmacies and pharmacists. Ms Purcell read law at University College Dublin and qualified as a chartered accountant with PricewaterhouseCoopers. She worked in a number of different industries before joining the Irish Medicines Board.
Dr. J.G. Beechinor, Director of Veterinary Sciences
Gabriel Beechinor M.V.B., M.V.M, MSc., PhD., C.Dip.A.F., M.R.C.V.S qualified as a veterinary surgeon having attained both Bachelor’s and Master’s Degrees in Veterinary Medicine from University College, Dublin. Following several years in practice, he joined the regulatory authority and having served as a Veterinary Assessor for 12 years, was appointed head of department with responsibility for marketing authorisations of veterinary medicinal products in 1999. Dr. Beechinor is a member of the Poisons Council and is alternate member of the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency having previously served as a CVMP member for 13 years. Dr. Beechinor achieved a Doctor of Philosophy degree from Trinity College Dublin in 2001 as well as a distinction in his Master’s of Science degree in Executive Leadership from the University of Ulster, Northern Ireland in 2010.
Dr. Jayne Crowe, Director of Human Products Authorisation and Registration
Jayne Crowe MB BCh BAO, MRCGP, DRCOG, DCH, DTM, PG Dip. Pharm Med, qualified in medicine from Queen’s University in Belfast. Dr Crowe has worked in clinical medicine both in the hospital setting and as a General Practitioner and is on the Specialist Register of General Practice. She is a Member of the Royal College of General Practitioners, an Adjunct Assistant Professor in Pharmaceutical Medicine, Pharmacology and Therapeutics and a member of the Management Committee of the Masters in Pharmaceutical Medicine at Trinity College. Jayne is a member of the National Committee for Clinical Effectiveness, a Committee member of the Association of Pharmaceutical Physicians of Ireland and a delegate on the European Commission’s Safe and Timely Access to Medicines for Patients’ Committee. Prior to her appointment as Director, Jayne as Clinical Assessment Manager, represented the HPRA at EU level at the Coordination Group for Mutual Recognition and Decentralised procedures (CMDh). She is currently the Chair of the EU Joint Good Clinical Practice Inspectors’ Working Group/CMDh, Working Party
| || |
Dr. Caitriona Fisher, Director of Quality, Scientific Affairs & Communications
Caitríona Fisher, BSc(Pharm), MBA, PhD, MPSI, qualified as a pharmacist in 1983 and following completion of a PhD worked in community and hospital pharmacies and as a researcher in community practice. She joined the National Drugs Advisory Board in 1988 as a pharmaceutical assessor, gaining considerable experience in scientific and regulatory affairs in relation to marketing authorisations and clinical trials. Prior to her appointment as Director of Quality, Scientific Affairs and Communications, Dr Fisher was manager of the Chief Executive’s Office. She currently chairs the EU medicines agencies’ Working Group of Quality Managers and the Pharmacovigilance Audit Facilitation Group.
| || ||Dr. Joan Gilvarry, Director of Human Products Monitoring |
Joan Gilvarry, M.B., B.Ch., B.A.O., D.Ch., F.R.C.P.I., qualified in medicine in the Royal
College of Surgeons in Ireland. Prior to her joining the Irish Medicines Board she
worked as a Lecturer of Medicine in the Meath/Adelaide hospitals
and Trinity College and is on the Specialist Register in
Gastroenterology. Dr. Gilvarry is a Fellow of the Royal College of
Physicians of Ireland and Fellow of the Royal Academy of
Medicine. She is a member of the National Immunisation Advisory
Committee, the Pandemic Influenza Expert group and the Irish
Sports Council’s Anti-Doping Committee.
| || || Mr. Kevin Horan, Director of ICT and Business Services |
Kevin Horan joined the then Irish Medicines Board in 2002. As director, his responsibilities include ICT, project management, business analysis and process improvement services. Mr Horan is currently the vice –chair of the European electronic submission group and a member of the European Telematics Management Board. Before joining the Irish Medicines Board, Mr Horan worked in the pharmaceutical industry in both manufacturing and distribution.
| || || |
| || ||Mr. John Lynch, Director of Compliance |
John Lynch, B.Sc (Pharm), M.Sc., M.P.S.I., is responsible for the inspection, licensing, market compliance and enforcement
activities. He qualified as a pharmacist from University College
Dublin in 1977 and became a member of the Pharmaceutical Society of
Ireland the following year. In 1980, he graduated from Trinity College
Dublin with an M.Sc. in Pharmacognosy.
From 1980 to 1987, he worked with Ricesteele & Co. in product
development, quality control and quality assurance. In 1987, he joined the
National Drugs Advisory Board (NDAB) as a GMP / GDP inspector and, in
1996, became Director of Inspection when the IMB succeeded the NDAB.
With the addition of further activities and the reorganisation of the
department in 2005, his job title was changed to Director of Compliance. He
is a past member of the Inspectors Working Group at the EMA and of the Committee of Officials of the
Pharmaceutical Inspection Co-Operation Scheme (PIC/S)
| ||Ms. Lynsey Perdisatt, Director of Human Resources and Change |
Lynsey Perdisatt, B.A., PgDip (Business Studies), M.B.S. (HR Strategies), joined the HPRA in 2006. Lynsey previously held a number of roles in the private sector gaining significant experience in employee relations, industrial relations and change management. Prior to her appointment as Director of Human Resources and Change, she held the role of HR Manager in the HPRA. Leading the HR team areas of responsibility included; departmental and organisational strategic planning, workforce planning, resource management, performance management and the delivery of a range of learning, development and coaching initiatives.
As Director of Human Resources and Change, Lynsey is responsible for the development and delivery of Human Resources and Change strategy, the design and implementation of HR solutions and the effective management of change projects that provide for the availability, effective use and engagement of human resources within the HPRA.
Lynsey is a member of the Chartered Institute of Personnel Development and is a qualified workplace mediator and investigator of disputes and conflict.